Words of Advice:

"If Something Seems To Be Too Good To Be True, It's Best To Shoot It, Just In Case." -- Fiona Glenanne

"Flying the Airplane is More Important than Radioing Your Plight to a Person on the Ground
Who is Incapable of Understanding or Doing Anything About It." -- Unknown

“Never argue with stupid people, they will drag you down to their level
and then beat you with experience.” -- Mark Twain

"Stay Strapped or Get Clapped." -- probably not Mr. Rogers

"Eck!" -- George the Cat

Wednesday, August 24, 2016

Pharma Bro's Spiritual Sister: Pharma Sis

(Followup post)
EpiPen prices aren't the only thing to jump at Mylan. Executive salaries have also seen a stratospheric uptick.

Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch's total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase, according to data provided by Connecture.
The story goes on to note that during the same period, Mylan increased their congressional bribery lobbying by four-fold, which resulted in the FDA's requiring that EpiPens be sold in two-pen sets, not singly, and that schools were given grants to stock them. Given that Bresch is the daughter of a U.S. Senator, it probably wasn't a terribly hard lobbying project.

That's what you're paying for in drug prices: Greedhead executives raising their own pay from "stratospheric" to "unconscionable" and spreading money in D.C. to get more corporate welfare.

Isn't capitalism wonderful?


Old NFO said...

And don't forget, her daddy is Sen. Joe Manchin... Looks like that acorn didn't fall far from the tree, did it?

3383 said...

Is there no generic version?

3383 said...

hate to answer myself, but yes-

Plus regular syringes.

Mylen is still full of shit.

New Jovian Thunderbolt said...

That's not capitalism

CenterPuke88 said...

The generics cannot be substituted for the prescribed device. Federal regulations on these syringes requires the rx be name specific, neither the pharmacy (nor the patient) can authorize the rx to be filled as a generic. This is just one of the obstacles placed by strangely specific regulations on these particular items. Another competing product was recalled last year for "use failures", failures that were generally the result of user error...errors that occur as often with Epi-pen but that did not trigger a similar recall. Now that we know the Mylan CEO's connections and Mylan's funding of politicians, the picture becomes clearer.

dinthebeast said...

I saw a video tonight of Pharma Bro saying that he thinks she's just ducky...

-Doug in Oakland

Comrade Misfit said...

Doug, I guess rats recognize their kin.

Sevesteen said...

Capitalism is great. Crony capitalism not so much.

3383 said...

Who is writing the prescription? If my doctor was prescribing EpiPen, I'd definitely have a discussion with him/ her.